F144-0234 Screening compound: 2-[4-(1-{[(2H-1,3-benzodioxol-5-yl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

F144-0234 Screening compound: 2-[4-(1-{[(2H-1,3-benzodioxol-5-yl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide
F144-0234 Screening compound: 2-[4-(1-{[(2H-1,3-benzodioxol-5-yl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F144-0234
2-[4-(1-{[(2H-1,3-benzodioxol-5-yl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F144-0234

Molecular Formula

C28H26N4O6 (C28 H26 N4 O6)

Compound Name

2-[4-(1-{[(2H-1,3-benzodioxol-5-yl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

IUPAC name

2-[4-(1-{[(2H-13-benzodioxol-5-yl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)phenyl]-N-propylacetamide

SMILES

CCCNC(Cc(cc1)ccc1N(C(c(cccc1)c1N1CC(Nc(cc2)cc3c2OCO3)=O)=O)C1=O)=O

InChI

InChI=1S/C28H26N4O6/c1-2-13-29-25(33)14-18-7-10-20(11-8-18)32-27(35)21-5-3-4-6-22(21)31(28(32)36)16-26(34)30-19-9-12-23-24(15-19)38-17-37-23/h3-12,15H,2,13-14,16-17H2,1H3,(H,29,33)(H,30,34)

InChI Key

PKRWQWJFVXXQGX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27104411

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.54

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.184

Distribution Coefficient, logD

2.184

Water Solubility, LogSw

-3.15

Polar Surface Area

95.233

Acid Dissociation Constant (pKa)

11.63

Base Dissociation Constant (pKb)

2.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

F144-0234 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with F144-0234 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F144-0234?
Check Price and Availability of F144-0234, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F144-0234 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F144-0234
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F144-0234
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F144-0234 available by request